Shrikant Chouhan turns bullish on Mankind Pharma and Dr Lal
In short
Shrikant Chouhan of Kotak Neo said he is bullish on two healthcare stocks: Mankind Pharma and Dr Lal Pathlabs.
This matters because his view may support investor interest in both names. The report does not say why he likes them or give a target price.
What the reporting says
Shrikant Chouhan of Kotak Neo shared a bullish view on Mankind Pharma and Dr Lal Pathlabs in a market call on two healthcare stocks. The publisher summary did not include the reason for the view, any target price, or any buy level. The immediate implication is supportive commentary for the two stocks, but the reporting does not establish any trade or earnings trigger.
Why it matters
Shrikant Chouhan of Kotak Neo shared a bullish view on Mankind Pharma and Dr Lal Pathlabs, according to the publisher summary. No price target, valuation call, or reason for the view was provided. The note is relevant for investors tracking healthcare stocks, but it does not establish a company event, earnings update, or regulatory development.